Cargando…
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
Antibodies elicited by infection accumulate somatic mutations in germinal centers that can increase affinity for cognate antigens. We analyzed 6 independent groups of clonally related severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Spike receptor-binding domain (RBD)-specific antibodies...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323339/ https://www.ncbi.nlm.nih.gov/pubmed/34331873 http://dx.doi.org/10.1016/j.immuni.2021.07.008 |
_version_ | 1783731223058710528 |
---|---|
author | Muecksch, Frauke Weisblum, Yiska Barnes, Christopher O. Schmidt, Fabian Schaefer-Babajew, Dennis Wang, Zijun C. Lorenzi, Julio C. Flyak, Andrew I. DeLaitsch, Andrew T. Huey-Tubman, Kathryn E. Hou, Shurong Schiffer, Celia A. Gaebler, Christian Da Silva, Justin Poston, Daniel Finkin, Shlomo Cho, Alice Cipolla, Melissa Oliveira, Thiago Y. Millard, Katrina G. Ramos, Victor Gazumyan, Anna Rutkowska, Magdalena Caskey, Marina Nussenzweig, Michel C. Bjorkman, Pamela J. Hatziioannou, Theodora Bieniasz, Paul D. |
author_facet | Muecksch, Frauke Weisblum, Yiska Barnes, Christopher O. Schmidt, Fabian Schaefer-Babajew, Dennis Wang, Zijun C. Lorenzi, Julio C. Flyak, Andrew I. DeLaitsch, Andrew T. Huey-Tubman, Kathryn E. Hou, Shurong Schiffer, Celia A. Gaebler, Christian Da Silva, Justin Poston, Daniel Finkin, Shlomo Cho, Alice Cipolla, Melissa Oliveira, Thiago Y. Millard, Katrina G. Ramos, Victor Gazumyan, Anna Rutkowska, Magdalena Caskey, Marina Nussenzweig, Michel C. Bjorkman, Pamela J. Hatziioannou, Theodora Bieniasz, Paul D. |
author_sort | Muecksch, Frauke |
collection | PubMed |
description | Antibodies elicited by infection accumulate somatic mutations in germinal centers that can increase affinity for cognate antigens. We analyzed 6 independent groups of clonally related severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Spike receptor-binding domain (RBD)-specific antibodies from 5 individuals shortly after infection and later in convalescence to determine the impact of maturation over months. In addition to increased affinity and neutralization potency, antibody evolution changed the mutational pathways for the acquisition of viral resistance and restricted neutralization escape options. For some antibodies, maturation imposed a requirement for multiple substitutions to enable escape. For certain antibodies, affinity maturation enabled the neutralization of circulating SARS-CoV-2 variants of concern and heterologous sarbecoviruses. Antibody-antigen structures revealed that these properties resulted from substitutions that allowed additional variability at the interface with the RBD. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying SARS-CoV-2 populations, and perhaps against other pandemic threat coronaviruses. |
format | Online Article Text |
id | pubmed-8323339 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Authors. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83233392021-07-30 Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations Muecksch, Frauke Weisblum, Yiska Barnes, Christopher O. Schmidt, Fabian Schaefer-Babajew, Dennis Wang, Zijun C. Lorenzi, Julio C. Flyak, Andrew I. DeLaitsch, Andrew T. Huey-Tubman, Kathryn E. Hou, Shurong Schiffer, Celia A. Gaebler, Christian Da Silva, Justin Poston, Daniel Finkin, Shlomo Cho, Alice Cipolla, Melissa Oliveira, Thiago Y. Millard, Katrina G. Ramos, Victor Gazumyan, Anna Rutkowska, Magdalena Caskey, Marina Nussenzweig, Michel C. Bjorkman, Pamela J. Hatziioannou, Theodora Bieniasz, Paul D. Immunity Article Antibodies elicited by infection accumulate somatic mutations in germinal centers that can increase affinity for cognate antigens. We analyzed 6 independent groups of clonally related severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Spike receptor-binding domain (RBD)-specific antibodies from 5 individuals shortly after infection and later in convalescence to determine the impact of maturation over months. In addition to increased affinity and neutralization potency, antibody evolution changed the mutational pathways for the acquisition of viral resistance and restricted neutralization escape options. For some antibodies, maturation imposed a requirement for multiple substitutions to enable escape. For certain antibodies, affinity maturation enabled the neutralization of circulating SARS-CoV-2 variants of concern and heterologous sarbecoviruses. Antibody-antigen structures revealed that these properties resulted from substitutions that allowed additional variability at the interface with the RBD. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying SARS-CoV-2 populations, and perhaps against other pandemic threat coronaviruses. The Authors. Published by Elsevier Inc. 2021-08-10 2021-07-30 /pmc/articles/PMC8323339/ /pubmed/34331873 http://dx.doi.org/10.1016/j.immuni.2021.07.008 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Muecksch, Frauke Weisblum, Yiska Barnes, Christopher O. Schmidt, Fabian Schaefer-Babajew, Dennis Wang, Zijun C. Lorenzi, Julio C. Flyak, Andrew I. DeLaitsch, Andrew T. Huey-Tubman, Kathryn E. Hou, Shurong Schiffer, Celia A. Gaebler, Christian Da Silva, Justin Poston, Daniel Finkin, Shlomo Cho, Alice Cipolla, Melissa Oliveira, Thiago Y. Millard, Katrina G. Ramos, Victor Gazumyan, Anna Rutkowska, Magdalena Caskey, Marina Nussenzweig, Michel C. Bjorkman, Pamela J. Hatziioannou, Theodora Bieniasz, Paul D. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations |
title | Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations |
title_full | Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations |
title_fullStr | Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations |
title_full_unstemmed | Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations |
title_short | Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations |
title_sort | affinity maturation of sars-cov-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323339/ https://www.ncbi.nlm.nih.gov/pubmed/34331873 http://dx.doi.org/10.1016/j.immuni.2021.07.008 |
work_keys_str_mv | AT mueckschfrauke affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT weisblumyiska affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT barneschristophero affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT schmidtfabian affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT schaeferbabajewdennis affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT wangzijun affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT clorenzijulioc affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT flyakandrewi affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT delaitschandrewt affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT hueytubmankathryne affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT houshurong affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT schifferceliaa affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT gaeblerchristian affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT dasilvajustin affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT postondaniel affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT finkinshlomo affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT choalice affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT cipollamelissa affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT oliveirathiagoy affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT millardkatrinag affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT ramosvictor affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT gazumyananna affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT rutkowskamagdalena affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT caskeymarina affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT nussenzweigmichelc affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT bjorkmanpamelaj affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT hatziioannoutheodora affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations AT bieniaszpauld affinitymaturationofsarscov2neutralizingantibodiesconferspotencybreadthandresiliencetoviralescapemutations |